“Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool.”, Addict Sci Clin Pract, vol. 14, no. 1, p. 39, 2019.
, “Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials.”, Front Med (Lausanne), vol. 6, p. 122, 2019.
, “Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation.”, JAMA Oncol, 2019.
, “Finding Common Ground and Advancing Engagement in Citizen Science.”, Narrat Inq Bioeth, vol. 9, no. 1, pp. 41-45, 2019.
, “Frailty in medically complex individuals with chronic HIV.”, AIDS, vol. 33, no. 10, pp. 1603-1611, 2019.
, , “Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.”, Biol Blood Marrow Transplant, vol. 25, no. 5, pp. e174-e178, 2019.
, “Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.”, Genes Immun, vol. 20, no. 4, pp. 281-292, 2019.
, “Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study.”, Infect Dis Obstet Gynecol, vol. 2019, p. 5430493, 2019.
, “Imaging Characteristics of Choroidal Neovascular Lesions in the AREDS2-HOME Study: Report Number 4.”, Ophthalmol Retina, vol. 3, no. 4, pp. 326-335, 2019.
, “Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).”, Implement Sci, vol. 14, no. 1, p. 48, 2019.
, , “The integrated National NeuroAIDS Tissue Consortium database: a rich platform for neuroHIV research.”, Database (Oxford), vol. 2019, 2019.
, , “It’s not just what you do, it’s how you do it: Variation in substance use screening outcomes with commonly used screening approaches in primary care clinics”, in AMERSA 43rd Annual National Conference, Boston, MA, 2019.
, “Kinematic risky driving behavior among younger and older drivers: Differences over time by age group and sex.”, Traffic Inj Prev, vol. 20, no. 7, pp. 708-712, 2019.
, “Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.”, Vaccine, vol. 37, no. 14, pp. 1978-1986, 2019.
, “LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.”, Retina, vol. 39, no. 9, pp. 1802-1809, 2019.
, “Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool.”, J Empir Res Hum Res Ethics, vol. 14, no. 2, pp. 95-106, 2019.
, “Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.”, Vaccine, vol. 37, no. 30, pp. 4008-4014, 2019.
, “Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.”, Vaccine, vol. 37, no. 30, pp. 4001-4007, 2019.
, “Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.”, JAMA Ophthalmol, vol. 137, no. 3, pp. 281-287, 2019.
, , “Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.”, J Allergy Clin Immunol, vol. 143, no. 2, pp. 651-661.e9, 2019.
, “Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.”, Pediatrics, vol. 143, no. 1, 2019.
,